Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab

Dermatol Ther. 2020 Jul;33(4):e13708. doi: 10.1111/dth.13708. Epub 2020 Jun 26.

Authors

Mario Valenti^{1

2}, Paola Facheris^{1

2}, Giulia Pavia^{1

2}, Luigi Gargiulo^{1

2}, Riccardo Giovanni Borroni^{1

2}, Antonio Costanzo^{1

2}, Alessandra Narcisi¹

Affiliations

¹ Department of Dermatology, Humanitas Clinical and Research Center-IRCCS, Milan, Italy.
² Department of Biomedical Sciences, Humanitas University, Milan, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / therapeutic use*
Antirheumatic Agents / therapeutic use*
Arthritis, Psoriatic / drug therapy*
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Disease Progression
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
SARS-CoV-2

Substances

Antirheumatic Agents
Adalimumab